CryoLife: EPS Increases, Revenues Up 21%
Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or $0.13 per share, compared to […]
Member Spotlight
Clarient: Q3 Revenues up 59%; Raises Guidance
Third quarter revenues at Clarient increased 59% to $19.0 million from the $11.9 million reported in Q3 2007. This marks the company’s 17th consecutive quarter […]
Treating Disc Degeneration from the Inside Out: New Preclinical Data from ISTO Technologies
ISTO Technologies announced positive preclinical data for its spinal disc repair therapy, NuQu. In collaboration with the University of California San Francisco (UCSF), ISTO is […]
Medtech Insight: In3 East
Meet the most important people in medical technology at In3 East, the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives. […]
NeoChord Receives Cash Infusion from Clarian Health Ventures
An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. […]
2008 European MedTech Summit
The 2008 European MedTech Summit, taking place in Switzerland on November 19-20th, will highlight 25 of the most promising European MedTech companies. The Summit provides […]
SyntheMed Raises $4 Million
SyntheMed closed on a $4.0 million private placement today. Investors were issued 10 million shares valued at $0.40 each plus 10 million three-year warrant entitling […]
Definiens Collaboration to Add Technological Muscle to Clarient’s Offerings in Personalized Medicine
In a move that could accelerate the growth of the Clarient’s biomarker business, the company announced Friday that, with Definiens, it will develop and commercialize […]
NovaDel Investors Restless as FDA Extends Approval Timeframe for Zolpimist
The FDA has requested an extension of “up to three months” in order to complete the review of the NovaDel’s Zolpimist Oral Spray for the […]
[Video Profile] Arterial Remodeling Technologies
Arterial Remodeling Technologies (ART) is developing bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty. ART’s bioresorbable […]